Effect of Leventhal's self-regulatory intervention on the hypertensive patients' illness perception and lifestyle: a randomized controlled trial.

Hypertension Illness perception Lifestyle Self-regulatory model

Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
26 01 2023
Historique:
received: 09 07 2022
accepted: 06 01 2023
entrez: 26 1 2023
pubmed: 27 1 2023
medline: 31 1 2023
Statut: epublish

Résumé

The perception of illness may lead to improving the hypertensive patients' lifestyle, but no study was found in this regard. Therefore, this study was conducted to determine the effect of intervention based on Leventhal's self-regulatory model on the illness perception and lifestyle of patients with hypertension. In the present randomized controlled trial study, ninety eligible patients with primary hypertension were randomly assigned to one of the two groups of intervention and control. Patients in the intervention group received five sessions of Leventhal's self-regulatory intervention, each of 60 min and weekly. However the control group received routine care. The outcomes were illness perception and lifestyle of the patients with hypertension. The Revised Illness Perception Questionnaire and the Lifestyle Questionnaire were administered to assess illness perception and lifestyle before the treatment to establish a baseline and subsequently 12 weeks after the intervention. The collected data were analyzed using statistical IMB SPSS software, version 21. Qualitative data were analyzed using Chi-Square test or Fisher's Exact test, and the Independent Sample t- test and Paired Sample t- test were used for analyzing quantitative data. Leventhal's self-regulatory intervention improved subscales of illness perception (p < 0.05) except for emotional representations and consequences. The global mean scores of the hypertensive patients ̓ lifestyle in the intervention group significantly increased from 102.8 ± 2.3 at the baseline to 112.1 ± 3 post-intervention. Interventions based on Leventhal's self-regulatory model could improve the illness perception and lifestyle of patients with hypertension. Trial registration The present randomized controlled trial study was registered on the Iranian Registry of Clinical Trials Website (IRCT); ID: IRCT20141222020401N6 on 8/5/2019.

Sections du résumé

BACKGROUND
The perception of illness may lead to improving the hypertensive patients' lifestyle, but no study was found in this regard. Therefore, this study was conducted to determine the effect of intervention based on Leventhal's self-regulatory model on the illness perception and lifestyle of patients with hypertension.
METHODS
In the present randomized controlled trial study, ninety eligible patients with primary hypertension were randomly assigned to one of the two groups of intervention and control. Patients in the intervention group received five sessions of Leventhal's self-regulatory intervention, each of 60 min and weekly. However the control group received routine care. The outcomes were illness perception and lifestyle of the patients with hypertension. The Revised Illness Perception Questionnaire and the Lifestyle Questionnaire were administered to assess illness perception and lifestyle before the treatment to establish a baseline and subsequently 12 weeks after the intervention. The collected data were analyzed using statistical IMB SPSS software, version 21. Qualitative data were analyzed using Chi-Square test or Fisher's Exact test, and the Independent Sample t- test and Paired Sample t- test were used for analyzing quantitative data.
RESULTS
Leventhal's self-regulatory intervention improved subscales of illness perception (p < 0.05) except for emotional representations and consequences. The global mean scores of the hypertensive patients ̓ lifestyle in the intervention group significantly increased from 102.8 ± 2.3 at the baseline to 112.1 ± 3 post-intervention.
CONCLUSIONS
Interventions based on Leventhal's self-regulatory model could improve the illness perception and lifestyle of patients with hypertension. Trial registration The present randomized controlled trial study was registered on the Iranian Registry of Clinical Trials Website (IRCT); ID: IRCT20141222020401N6 on 8/5/2019.

Identifiants

pubmed: 36703112
doi: 10.1186/s12872-023-03049-6
pii: 10.1186/s12872-023-03049-6
pmc: PMC10127530
doi:

Banques de données

IRCT
['IRCT20141222020401N6']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

50

Informations de copyright

© 2023. The Author(s).

Références

J Psychosom Res. 2009 Jul;67(1):11-5
pubmed: 19539813
J Res Med Sci. 2016 Dec 26;21:125
pubmed: 28331511
Glob J Health Sci. 2015 Mar 26;7(7 Spec No):6-16
pubmed: 26153198
Nurs Res. 2012 Mar-Apr;61(2):111-20
pubmed: 22282154
Medicine (Baltimore). 2021 May 7;100(18):e25192
pubmed: 33950917
Ann Behav Med. 2017 Oct;51(5):629-641
pubmed: 28244003
J Lifestyle Med. 2016 Sep;6(2):58-63
pubmed: 27924284
BMC Psychol. 2014 Nov 28;2(1):50
pubmed: 25520809
Eur J Public Health. 2007 Aug;17(4):329-30
pubmed: 17670810
Lancet Glob Health. 2018 Jan;6(1):e66-e73
pubmed: 29241617
Int J Community Based Nurs Midwifery. 2019 Oct;7(4):279-287
pubmed: 31641677
Heart Lung. 2006 Sep-Oct;35(5):293-300
pubmed: 16963361
Prev Med Rep. 2016 Sep 28;4:525-531
pubmed: 27747149
ERJ Open Res. 2017 Dec 08;3(4):
pubmed: 29250529
Gynecol Oncol. 2017 May;145(2):310-318
pubmed: 28279480
Health Psychol Open. 2019 Apr 23;6(1):2055102919844504
pubmed: 31041109
J Clin Nurs. 2009 Aug;18(15):2234-44
pubmed: 19583655
Int Arch Occup Environ Health. 2010 Aug;83(6):595-605
pubmed: 20130906
J Clin Hypertens (Greenwich). 2011 Nov;13(11):836-42
pubmed: 22051429
Psychosom Med. 2002 Jul-Aug;64(4):580-6
pubmed: 12140347
J Adv Nurs. 2015 Nov;71(11):2540-50
pubmed: 26105004
Int J Nurs Stud. 2014 Jun;51(6):844-55
pubmed: 24211192
J Psychosom Res. 2006 Dec;61(6):757-67
pubmed: 17141663
BMC Res Notes. 2017 Nov 28;10(1):629
pubmed: 29183367
BMC Nurs. 2016 Jun 01;15:34
pubmed: 27252595
Psicol Reflex Crit. 2017 Dec 22;30(1):26
pubmed: 32025986

Auteurs

Fatemeh Saranjam (F)

Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.

Ardashir Afrasiabifar (A)

Professor of Nursing, Yasuj University of Medical Sciences, Yasuj, Iran.

Alikaram Alamdari (A)

Nursing Department, Nursing School, Yasuj University of Medical Sciences, Yasuj, Iran.

Nazafarin Hosseini (N)

Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran. hosseinichenar@yahoo.com.
School of Nursing, Yasuj University of Medical Sciences, Yasuj, Iran. hosseinichenar@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH